• Gregoriadis, G. [ed.] (2007) Liposome Technology. Third edition. Volume II: Entrapment of Drugs and Other Materials into Liposomes. New York, NY: Informa Healthcare USA, Inc.
• Gregoriadis, G. [ed.] (2007) Liposome Technology. Third edition. Volume III: Interactions of Liposomes with the Biological Milieu. New York, NY: Informa Healthcare USA, Inc.
• Hickey, S., H. Roberts, and N. Miller. (2008) Pharmacokinetics of oral vitamin C. Journal of Nutritional & Environmental Medicine July 31.
• Hadavi D, Poot AA (2016) Biomaterials for the Treatment of Alzheimer’s Disease; Frontiers in Bioengineering and Biotechnology 4:49
• Hemanthkumar M, Spandana V (2011): Liposomal encapsulation technology a novel drug delivery designed for ayurvedic drug preparation; International Research Journal of Pharmacy 2(10):4-6
• Hoesel, L., M. Flierl, A. Niederbichler, D. Rittirsch, S. McClintock, J. Reuben, M. Pianko, W. Stone, H. Yang, M. Smith, J. Sarma, and P. Ward. (2008) Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury. Antioxidants & Redox Signaling 10(5):973-981.
• Imaizumi, S., V. Woolworth, R. Fishman, and P. Chan. (1990) Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21(9):1312-1317.
• Jiao Z, Wang X, Yin Y, Xia J, Mei Y. (2018) Preparation and evaluation of a chitosan-coated antioxidant liposome containing vitamin C and folic acid. J Microencapsul ;35(3):272-280. doi: 10.1080/02652048.2018.1467509. PMID: 29671362
• Jubeh, T., M. Nadler-Milbauer, Y. Barenholz, and A. Rubinstein. (2006) Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, T MN and SOD. Journal of Drug Targeting 14(3):155-163.
• Junghans, A., H. Sies, and W. Stahl. (2000) Carotenoid-containing unilamellar liposomes loaded with glutathione: a model to study hydrophobic-hydrophilic antioxidant interaction. Free Radical Research 33(6):801-808.
• Kasbo, J., B. Tuchweber, S. Perwaiz, G. Bouchard, H. Lafont, N. Domingo, F. Chanussot and I. Yousef. (2003) Phosphatidylcholine enriched diet prevents gallstone formation in mice susceptible to cholelithiasis. Journal of Lipid Research 44(12):2297-2303.
• Konno, H., A. Matin, Y. Maruo, 5. Nakamura, and S. Baba. (1996) Liposomal ATP protects the liver from injury during shock. European Surgica/·Research 28(2): 140-145.
• Korb, V., K. Tep, V. Escriou, C. Richard, D. Scherman, L. Cynober, J. Chaumeil, and G. Dumortier. (2008) Current data on ATPcontaining liposomes and potential prospects to enhance cellular energy status for hepatic applications. Critical Reviews in Therapeutic Drug Carrier Systems 25(4):305-345.
• Lamireau, T., G. Bouchard, I. Yousef, H. Clouzeau-Girard, J. Rosenbaum, A. Desmouliere and B. Tuchweber. (2007) Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice. Pediatric Research 61(2):185-190.
• Lee, S., H. Yuk, D. Lee, K. Lee, Y. Hwang and R. Ludescher. (2002) Stabilization of retinal through incorporation into liposomes. Journal of Biochemistry and Molecular Biology 35(4) :358-363.
• Lee, S., Y. Han, B. Min, and I. Park. (2003) Cytoprotective effects of polyenoylphosphatidylcholine (PPC) on beta-cells during diabetic induction by streptozotocin. The Journal of Histochemistry and Cy tochemistry 51(8):1005-1015.
• Levy, T. (2006) Stop America’s #1 Killer. Reversible Vitamin Deficiency Found to be Origin of ALL Coronary Heart Disease. Henderson, NV: LivOn Books.
• Liang, W., D. Johnson, and S. Jarvis. (2001) Vitamin C transport systems of mammalian cells. Molecular Membrane Biology 18(1):87-95.
• Lieber, C. (2004) Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34(1):9-19.
• Ling, S., E. Magosso, N. Khan, K. Yuen, and S. Barker. (2006) Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Development and Industrial Pharmacy 32(3):335-345.
• Lubin, B., S. Shohet, and D. Nathan. (7972) Changes in fatty acid metabolism after erythrocyte peroxidation: stimulation of a membrane repair process. The Journal of Clinical Investigation 51(2):338-344.
• Maheshwari, H., R. Agarwal, C. Patil and O.Katare. (2003) Preparation and pharmacological evaluation of silibinin liposomes. ArzneimitteIforschung 53(6) :420 – 427.
• Mandal, A., S. Das, M. Basu, R. Chakrabarti and N. Das. (2007) Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis. The Journal of Pharmacology and Experimental Therapeutics 320(3):994-1001.
• Mastellone, I., E. Polichetti, S. Gres, C. de la Maisonneuve, N. Domingo, V. Marin, A. Lorec, C. Farnarier, H. Portugal, G. Kaplanski, F. Chanussot. (2000) Dietary soybean phosphatidylcholines Iower lipidemia: mechanisms at the levels of intestine, endothelial cell, and hepato-biliary axis. The Journal of Nutritional Biochemistry 77(9) :467- 466.
• Meister, A. (1994) Glutathione-ascorbic acid antioxidant system in animals. The Journal of Biological Chemistry 269(13):9397-9400.• N., M. Babaei, A, Vali, F. Daha, F. Kobarfard, and S. Dadashzadeh. (2008) 99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability. Nuclear Medicine and Biology 35(3):387-392,